Literature DB >> 12950336

A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.

K S Leslie1, K Gaffney, C N Ross, S Ridley, T H Barker, J J Garioch.   

Abstract

Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis. Side-effects are common and include lethargy, headaches, methaemoglobinaemia and haemolysis. Severe adverse effects are rare but the dapsone hypersensitivity syndrome is well recognized. Symptoms include fever, haemolytic anaemia, lymphocytosis and hepatitis. We report a near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. This diagnosis should be remembered in any patient who becomes unwell whilst taking dapsone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950336     DOI: 10.1046/j.1365-2230.2003.01336.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.

Authors:  Hong Liu; Zhenzhen Wang; Fangfang Bao; Chuan Wang; Lele Sun; Huimin Zhang; Gongqi Yu; Zihao Mi; Jianke Li; Lulu Li; Qing Zhao; Zhenhua Yue; Wei Zhao; Wenjun Yu; Jing Cao; Fei Xiong; Yaru Wang; Zemin Chai; Xiujun Cheng; Yuan Zhang; Fanghui Fu; Xiaoqiao Lang; Xiaoling Wang; Astrid Irwanto; Hana Krismawati; Xi'an Fu; Yonghu Sun; Jiabao You; Jian Liu; Qing Pan; Tongsheng Chu; Dianchang Liu; Shumin Chen; Jianping Shen; Liangbin Yan; Guocheng Zhang; Jianjun Liu; Furen Zhang; Li Xiong; Jun Yang; Jinlan Li; Wei Ke; Ming Li; Yong Ning; Junhao Xiong; Ming Li; Mingzhou Xiong; Bin Yang; Qizhi Duan; Hong Wang; Wei Li; Yanfei Kuang; Junhua Li; Lamei Wang; Qiuyang Cao; Peng Xiao; Bangzhong Xiao; Lianhua Zhang; Zhaoxing Lin; Yaofei Wang; Yunliang Shen; Liying Yan; Wenbin Wu; Hu Zheng; Xianfa Zhan; Wanghua Li; Xiujian Shang; Yujun Xu; Qiao Liu
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

2.  The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.

Authors:  Semaan G Kosseifi; Bhuvana Guha; Dima N Nassour; David S Chi; Guha Krishnaswamy
Journal:  J Occup Med Toxicol       Date:  2006-06-06       Impact factor: 2.646

3.  Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.

Authors:  Hana Krismawati; Astrid Irwanto; Arry Pongtiku; Ishak Darryl Irwan; Yustinus Maladan; Yuli Arisanti Sitanggang; Tri Wahyuni; Ratna Tanjung; Yonghu Sun; Hong Liu; Furen Zhang; Antonius Oktavian; Jianjun Liu
Journal:  PLoS Negl Trop Dis       Date:  2020-10-16

4.  Dapsone hypersensitivity syndrome: A rare life threatening complication of dapsone therapy.

Authors:  Kolar Vishwanath Vinod; Karyampudi Arun; Tarun Kumar Dutta
Journal:  J Pharmacol Pharmacother       Date:  2013-04

5.  Case report of two cases of fever, rash, and organ involvement during the treatment of leprosy.

Authors:  Hong Liu; Chuan Wang; Tongsheng Chu; Parimi Leela Rani; Debao Yu; Xi'an Fu; Mingfei Chen; Shumin Chen; Furen Zhang
Journal:  PLoS Negl Trop Dis       Date:  2014-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.